P3 Health Partners(US:PIII) ZACKSยท2025-08-14 22:15Company Performance - P3 Health Partners Inc. reported a quarterly loss of $6.23 per share, significantly worse than the Zacks Consensus Estimate of a loss of $3.29, representing an earnings surprise of -89.36% [1] - The company's revenues for the quarter ended June 2025 were $355.79 million, missing the Zacks Consensus Estimate by 2.03%, and down from $379.16 million in the same quarter last year [2] - Over the last four quarters, P3 Health Partners has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] Stock Movement and Outlook - P3 Health Partners shares have declined approximately 36.9% since the beginning of the year, contrasting with a 10% gain in the S&P 500 [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current consensus EPS estimate for the upcoming quarter is -$5.04 on revenues of $342.9 million, and for the current fiscal year, it is -$16.60 on revenues of $1.43 billion [7] Industry Context - The Medical Info Systems industry, to which P3 Health Partners belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact P3 Health Partners' stock performance [5][6]